American College of Physicians: Internal Medicine — Doctors for Adults ®

Advertisement

ACP DiabetesMonthly

Welcome to this month's issue of ACP DiabetesMonthly, an update for internists published by the American College of Physicians.



In the News for the month of October 2014




Highlights

Hypertension treatment reduced long-term mortality, but intensive glucose control didn't

Hypertension treatment with perindopril-indapamide for 4.5 years had a long-lasting impact on mortality in patients with type 2 diabetes, but intensive glucose control was not associated with any significant benefit, a study found. More...

Metformin may be associated with low levels of thyroid-stimulating hormone, study finds

Metformin monotherapy may be linked to lower levels of thyroid-stimulating hormone compared with sulfonylurea monotherapy in patients with type 2 diabetes, according to a new study. More...

Phentermine/topiramate combo helps type 2 diabetes patients lose weight, control glucose

Obese and overweight patients with type 2 diabetes lost more weight and had better glycemic control when treated with phentermine/topiramate extended-release medication than with placebo, 2 industry-funded studies reported. More...


Test yourself

MKSAP quiz: Severe foot pain in type 1 diabetic

This month's quiz asks readers to evaluate a 42-year-old man with poorly controlled type 1 diabetes who has a 6-day history of severe burning and stabbing pain in both feet that is worse in the toes. More...


From ACP Journal Club

In newly diagnosed type 2 diabetes mellitus, a Mediterranean diet (vs. a low-fat diet) delayed start of glucose-lowering drugs

Patients who were randomized to a low-carbohydrate Mediterranean diet shortly after type 2 diabetes diagnosis delayed their need for medication compared to those put on a low-fat diet in an Italian trial. More...


From ACP Internist Weekly

GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis

Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a recent analysis of previous trials found. More...


Screening

USPSTF recommends screening asymptomatic adults for diabetes

The United States Preventive Services Task Force (USPSTF) is expanding the population it recommends screening for type 2 diabetes, according to a draft recommendation released this week. More...


FDA update

New GLP-1 agonist approved

A new glucagon-like peptide-1 (GLP-1) receptor agonist, dulaglutide (Trulicity), was approved to treat type 2 diabetes, along with diet and exercise, the FDA recently announced. More...


Keeping tabs

Spotlight on ethnic differences in diabetes

Two recent studies highlighted some differences among ethnic groups in risk and incidence of diabetes. More...


Physician editor: David V. O'Dell, MD, FACP



Has Your Contact Information Changed?

To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).

About Your Subscription

You are receiving this newsletter as a benefit of your ACP membership. To unsubscribe, simply send a blank e-mail to leave-105814-17003158N@acpnews.org.

ACP DiabetesMonthly is a monthly newsletter produced by the staff of ACP Internist. Please forward any comments or suggestions to acpinternist@acponline.org.

ACP respects your privacy and will not sell, lease or share your e-mail address with any other organization. The College will only use e-mail for the purpose of conducting College business and for communicating with College members.

Copyright © by American College of Physicians.

Test yourself

A 66-year-old man comes for a preoperative evaluation before total joint arthroplasty of the left knee. He has a 25-year history of rheumatoid arthritis. He has had progressive pain in his left knee with activity, which limits his ability to hike. The patient has similar pain in the right knee, but it is less severe. He reports no recent morning stiffness. He is able to climb two or three flights of stairs without chest pain or shortness of breath. He has no other medical problems and reports no additional symptoms. Medications are methotrexate and folic acid. Following a physical exam and lab tests, what is the next best step in management?

Find the answer

New Leadership Webinars

New Leadership Webinars

The ACP Leadership Academy is offering FREE webinars covering the core tenets of leadership, leadership in hospital medicine, finance, and more.

Join ACP Today!

Join ACP Today!

ACP membership connects you with like-minded colleagues and provides access to a variety of clinical resources, practice tools, and ways to earn MOC and CME.